Pictet Asset Management Holding SA »

Y Mabs Therapeutics shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-03-31 $12M 746k 16.26

More positions owned by Pictet Asset Management Holding SA

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
Apple (AAPL)
Amazon (AMZN)
Republic Services (RSG)
Alphabet Cap Stk Cl C (GOOG)
Nxp Semiconductors N V (NXPI)
Meta Platforms Cl A (META)
Waste Connections (WCN)
Synopsys (SNPS)
Applied Materials (AMAT)
Waste Management (WM)
Alphabet Cap Stk Cl A (GOOGL)
Xylem (XYL)

View all positions for Pictet Asset Management Holding SA

Top funds holding Y Mabs Therapeutics

BlackRock
Paradigm Biocapital Advisors
Sofinnova Ventures
Vanguard Group
Point72 Asset Management
D. E. Shaw & Co
Pictet Asset Management Holding SA
Geode Capital Management
Acadian Asset Management
Caligan Partners
Soleus Capital Management
Dimensional Fund Advisors
Goldman Sachs Group
Boothbay Fund Management
Northern Trust

View all funds holding Y Mabs Therapeutics